Anti-inflammatory drugs including 5-aminosalicylic acid (5-ASA), thiopurines, and anti-tumor necrosis factor (TNF)-α used in the treatment of IBD have also reduced colitis-associated cancer and have been firmly established as chemo-preventive [17]. The gene discussed is TNF; the disease is cancer.